CCDC18-AS1 is overexpressed in GC and independently predicts poor prognosis. It promotes GC progression by targeting miR-214-3p, thereby regulating key oncogenic processes.
Li et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: